Improved Culture System For Hepatitis C Virus Infection

Researchers have developed the first tissue culture of normal, human liver cells that can model infection with the hepatitis C virus and provide a realistic environment to evaluate possible treatments. The novel cell line will allow pharmaceutical companies to effectively test new drug candidates or possible vaccines for the HCV infection, which afflicts about 170 million people worldwide.

Read the whole article on Science Daily

More from Science Daily